Cogentix Medical Stock Price, News & Analysis (NASDAQ:CGNT)

$2.73 0.01 (0.37 %)
(As of 11/20/2017 04:00 PM ET)
Previous Close$2.72
Today's Range$2.69 - $2.78
52-Week Range$1.55 - $3.26
Volume19,638 shs
Average Volume60,927 shs
Market Capitalization$165.66 million
P/E RatioN/A
Dividend YieldN/A
Beta0.69

About Cogentix Medical (NASDAQ:CGNT)

Cogentix Medical logoCogentix Medical, Inc. is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB). The Company also offers Macroplastique Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence that is primarily due to intrinsic sphincter deficiency. The PrimeSight flexible endoscopes are used in conjunction with the sterile, single-use microbial barrier known as the EndoSheath Protective Barrier. The PrimeSight endoscopy line also includes rigid endoscopes and portable peripherals, such as the video system and stroboscopy unit.


Industry, Sector and Symbol:
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: N/A
  • Sector: Medical
  • Symbol: NASDAQ:CGNT
  • CUSIP: N/A
  • Web: www.cogentixmedical.com
Debt:
  • Current Ratio: 4.64%
  • Quick Ratio: 3.82%
Sales & Book Value:
  • Annual Sales: $51.85 million
  • Price / Sales: 3.21
  • Book Value: $1.05 per share
  • Price / Book: 2.60
Profitability:
  • Trailing EPS: ($0.41)
  • Net Income: ($22,090,000.00)
  • Net Margins: -36.14%
  • Return on Equity: -11.52%
  • Return on Assets: -10.04%
Misc:
  • Employees: 177
  • Outstanding Shares: 60,910,000
 

Frequently Asked Questions for Cogentix Medical (NASDAQ:CGNT)

What is Cogentix Medical's stock symbol?

Cogentix Medical trades on the NASDAQ under the ticker symbol "CGNT."

How were Cogentix Medical's earnings last quarter?

Cogentix Medical, Inc. (NASDAQ:CGNT) released its earnings results on Tuesday, November, 3rd. The medical device company reported ($0.06) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.07) by $0.01. The medical device company had revenue of $11.80 million for the quarter, compared to the consensus estimate of $11.45 million. Cogentix Medical had a negative return on equity of 11.52% and a negative net margin of 36.14%. View Cogentix Medical's Earnings History.

Where is Cogentix Medical's stock going? Where will Cogentix Medical's stock price be in 2017?

2 brokerages have issued twelve-month target prices for Cogentix Medical's stock. Their forecasts range from $4.00 to $5.00. On average, they anticipate Cogentix Medical's share price to reach $4.50 in the next year. View Analyst Ratings for Cogentix Medical.

Who are some of Cogentix Medical's key competitors?

Who are Cogentix Medical's key executives?

Cogentix Medical's management team includes the folowing people:

  • Uri Geiger, Chairman of the Board
  • Darin Hammers, President, Chief Executive Officer, Director
  • , Bio & Compensation - 
  • Brett A. Reynolds, Chief Financial Officer, Senior Vice President, Principal Financial Officer, Principal Accounting Officer, Secretary
  • Kenneth H. Paulus, Director
  • Cheryl Pegus M.D., Director
  • Lewis C. Pell, Director
  • Kevin H. Roche, Director
  • Nachum Shamir, Director

Who owns Cogentix Medical stock?

Cogentix Medical's stock is owned by many different of retail and institutional investors. Top institutional investors include Perkins Capital Management Inc. (0.92%) and Dimensional Fund Advisors LP (0.10%). Company insiders that own Cogentix Medical stock include Kenneth A Samet and Lewis C Pell. View Institutional Ownership Trends for Cogentix Medical.

Who sold Cogentix Medical stock? Who is selling Cogentix Medical stock?

Cogentix Medical's stock was sold by a variety of institutional investors in the last quarter, including Perkins Capital Management Inc.. View Insider Buying and Selling for Cogentix Medical.

Who bought Cogentix Medical stock? Who is buying Cogentix Medical stock?

Cogentix Medical's stock was bought by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP. Company insiders that have bought Cogentix Medical stock in the last two years include Kenneth A Samet and Lewis C Pell. View Insider Buying and Selling for Cogentix Medical.

How do I buy Cogentix Medical stock?

Shares of Cogentix Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cogentix Medical's stock price today?

One share of Cogentix Medical stock can currently be purchased for approximately $2.73.

How big of a company is Cogentix Medical?

Cogentix Medical has a market capitalization of $165.66 million and generates $51.85 million in revenue each year. The medical device company earns ($22,090,000.00) in net income (profit) each year or ($0.41) on an earnings per share basis. Cogentix Medical employs 177 workers across the globe.

How can I contact Cogentix Medical?

Cogentix Medical's mailing address is 5420 FELTL ROAD, MINNETONKA MN, 55343. The medical device company can be reached via phone at 952-426-6140 or via email at [email protected]


MarketBeat Community Rating for Cogentix Medical (NASDAQ CGNT)

Community Ranking:  1.6 out of 5 (star)
Outperform Votes:  53 (Vote Outperform)
Underperform Votes:  111 (Vote Underperform)
Total Votes:  164
MarketBeat's community ratings are surveys of what our community members think about Cogentix Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Cogentix Medical (NASDAQ:CGNT)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 2 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $4.50 (64.84% upside)

Consensus Price Target History for Cogentix Medical (NASDAQ:CGNT)

Price Target History for Cogentix Medical (NASDAQ:CGNT)

Analysts' Ratings History for Cogentix Medical (NASDAQ:CGNT)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/8/2017Roth CapitalInitiated CoverageBuy -> Buy$4.00N/AView Rating Details
10/6/2017JMP SecuritiesInitiated CoverageMkt Outperform -> Outperform$5.00N/AView Rating Details
(Data available from 11/20/2015 forward)

Earnings

Earnings History and Estimates Chart for Cogentix Medical (NASDAQ:CGNT)

Earnings by Quarter for Cogentix Medical (NASDAQ:CGNT)

Earnings History by Quarter for Cogentix Medical (NASDAQ CGNT)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/1/2017Q2 2017($0.01)$0.01$13.90 million$14.06 millionViewListenView Earnings Details
5/2/2017Q1 2017($0.01)($0.02)$13.14 million$12.95 millionViewListenView Earnings Details
3/9/2017Q4 2016($0.14)$13.81 million$13.23 millionViewListenView Earnings Details
11/3/2015Q216($0.07)($0.06)$11.45 million$11.80 millionViewN/AView Earnings Details
8/10/2015Q116($0.10)($0.07)$11.34 million$11.20 millionViewListenView Earnings Details
5/14/2015Q415($0.06)($0.15)$49.10 million$7.00 millionViewListenView Earnings Details
2/3/2014Q3 14($0.03)$4.00 million$4.50 millionViewN/AView Earnings Details
8/12/2013Q1 2014($0.05)$34.00 million$3.70 millionViewN/AView Earnings Details
11/5/2012Q213($0.06)($0.07)$3.85 million$3.70 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cogentix Medical (NASDAQ:CGNT)
2017 EPS Consensus Estimate: ($0.02)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.01)($0.01)($0.01)
Q2 20171$0.00$0.00$0.00
Q3 20171($0.01)($0.01)($0.01)
Q4 20171$0.00$0.00$0.00
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Cogentix Medical (NASDAQ:CGNT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Cogentix Medical (NASDAQ CGNT)

Insider Ownership Percentage: 62.70%
Institutional Ownership Percentage: 12.79%
Insider Trades by Quarter for Cogentix Medical (NASDAQ:CGNT)
Institutional Ownership by Quarter for Cogentix Medical (NASDAQ:CGNT)

Insider Trades by Quarter for Cogentix Medical (NASDAQ CGNT)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/18/2016Kenneth A SametDirectorBuy25,000$2.47$61,750.00View SEC Filing  
6/10/2016Lewis C PellDirectorBuy13,291$0.95$12,626.45View SEC Filing  
6/1/2016Lewis C PellDirectorBuy894$0.75$670.50View SEC Filing  
5/31/2016Lewis C PellDirectorBuy500,000$0.79$395,000.00View SEC Filing  
5/21/2015Kevin H RocheDirectorBuy10,000$1.68$16,800.00View SEC Filing  
5/19/2015Kevin H RocheDirectorBuy10,000$1.60$16,000.00View SEC Filing  
2/20/2015Lewis C PellDirectorBuy20,000$0.51$10,200.00View SEC Filing  
2/19/2015Lewis C PellDirectorBuy10,000$0.48$4,800.00View SEC Filing  
2/18/2015Lewis C PellDirectorBuy30,000$0.45$13,500.00View SEC Filing  
2/13/2015Lewis C PellDirectorBuy20,000$0.47$9,400.00View SEC Filing  
2/11/2015Lewis C PellDirectorBuy35,000$0.46$16,100.00View SEC Filing  
12/23/2014Lewis C PellDirectorBuy80,000$0.85$68,000.00View SEC Filing  
12/22/2014Lewis C PellDirectorBuy40,000$0.86$34,400.00View SEC Filing  
9/23/2014Lewis C PellDirectorBuy5,000$0.99$4,950.00View SEC Filing  
9/19/2014Lewis C PellDirectorBuy3,900$1.00$3,900.00View SEC Filing  
9/17/2014Lewis C PellDirectorBuy5,000$1.02$5,100.00View SEC Filing  
9/16/2014Lewis C PellDirectorBuy5,000$1.07$5,350.00View SEC Filing  
9/12/2014Lewis C PellDirectorBuy23,300$1.04$24,232.00View SEC Filing  
9/8/2014Lewis C PellDirectorBuy30,000$1.04$31,200.00View SEC Filing  
9/3/2014Lewis C PellDirectorBuy30,000$0.98$29,400.00View SEC Filing  
8/27/2014Lewis C PellDirectorBuy10,000$0.92$9,200.00View SEC Filing  
8/26/2014Lewis C PellDirectorBuy30,000$0.93$27,900.00View SEC Filing  
8/19/2014Lewis C PellDirectorBuy22,900$0.98$22,442.00View SEC Filing  
8/13/2014Lewis C PellDirectorBuy43,420$0.91$39,512.20View SEC Filing  
8/8/2014Lewis C PellDirectorBuy27,500$0.95$26,125.00View SEC Filing  
6/6/2014Lewis C PellDirectorBuy10,000$1.13$11,300.00View SEC Filing  
5/21/2014Lewis C PellDirectorBuy5,000$1.09$5,450.00View SEC Filing  
5/16/2014Lewis C PellDirectorBuy14,197$1.02$14,480.94View SEC Filing  
11/18/2013Lewis C PellDirectorBuy6,296$0.91$5,729.36View SEC Filing  
11/15/2013Lewis C PellDirectorBuy20,000$0.90$18,000.00View SEC Filing  
9/18/2013Lewis C PellDirectorBuy16,000$0.91$14,560.00View SEC Filing  
9/13/2013Lewis C PellDirectorBuy5,000$0.92$4,600.00View SEC Filing  
9/10/2013Lewis C PellDirectorBuy5,000$0.92$4,600.00View SEC Filing  
9/9/2013Lewis C PellDirectorBuy4,564$0.95$4,335.80View SEC Filing  
9/6/2013Lewis C PellDirectorBuy5,000$0.97$4,850.00View SEC Filing  
9/3/2013Lewis C PellDirectorBuy11,432$0.97$11,089.04View SEC Filing  
8/29/2013Lewis C PellDirectorBuy1,100$0.98$1,078.00View SEC Filing  
8/27/2013Lewis C PellDirectorBuy11,596$0.97$11,248.12View SEC Filing  
8/26/2013Lewis C PellDirectorBuy14,965$0.97$14,516.05View SEC Filing  
8/19/2013Lewis C PellDirectorBuy25,025$0.94$23,523.50View SEC Filing  
8/15/2013Lewis C PellDirectorBuy15,000$0.92$13,800.00View SEC Filing  
6/28/2013Lewis C PellDirectorBuy28,400$1.00$28,400.00View SEC Filing  
6/27/2013Lewis C PellDirectorBuy45,048$0.99$44,597.52View SEC Filing  
3/15/2013Lewis C PellDirectorBuy30,000$1.14$34,200.00View SEC Filing  
3/12/2013Lewis C PellDirectorBuy45,000$1.10$49,500.00View SEC Filing  
3/7/2013Lewis C PellDirectorBuy60,000$1.09$65,400.00View SEC Filing  
3/4/2013Lewis C PellDirectorBuy20,000$1.06$21,200.00View SEC Filing  
2/26/2013Lewis C PellDirectorBuy66,266$1.01$66,928.66View SEC Filing  
2/21/2013Lewis C PellDirectorBuy25,000$0.99$24,750.00View SEC Filing  
2/19/2013Lewis C PellDirectorBuy5,000$0.99$4,950.00View SEC Filing  
2/7/2013Lewis C PellDirectorBuy9,000$0.99$8,910.00View SEC Filing  
2/5/2013Lewis C PellDirectorBuy25,000$1.01$25,250.00View SEC Filing  
2/1/2013Lewis C PellDirectorBuy10,000$1.09$10,900.00View SEC Filing  
12/27/2012Lewis C PellDirectorBuy10,000$1.07$10,700.00View SEC Filing  
12/17/2012Lewis C PellDirectorBuy21,600$1.10$23,760.00View SEC Filing  
12/13/2012Lewis C PellDirectorBuy18,961$1.10$20,857.10View SEC Filing  
12/10/2012Lewis C PellDirectorBuy6,656$1.10$7,321.60View SEC Filing  
12/3/2012Lewis C PellDirectorBuy8,360$1.10$9,196.00View SEC Filing  
11/30/2012Lewis C PellDirectorBuy45,748$1.10$50,322.80View SEC Filing  
11/27/2012Lewis C PellDirectorBuy3,593$1.10$3,952.30View SEC Filing  
11/23/2012Lewis C PellDirectorBuy39,357$1.09$42,899.13View SEC Filing  
11/19/2012Lewis C PellDirectorBuy57,050$1.08$61,614.00View SEC Filing  
11/14/2012Lewis C PellDirectorBuy100,000$1.15$115,000.00View SEC Filing  
11/12/2012Lewis C PellDirectorBuy24,852$1.17$29,076.84View SEC Filing  
9/6/2012Lewis C PellDirectorBuy10,000$1.37$13,700.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Cogentix Medical (NASDAQ CGNT)

Source:
DateHeadline
Cogentix Medical (CGNT) vs. Edwards Lifesciences Corporation (EW) Head to Head SurveyCogentix Medical (CGNT) vs. Edwards Lifesciences Corporation (EW) Head to Head Survey
www.americanbankingnews.com - November 19 at 11:36 AM
Cogentix Medical, Inc. (CGNT) Upgraded to "C" at TheStreetCogentix Medical, Inc. (CGNT) Upgraded to "C" at TheStreet
www.americanbankingnews.com - November 11 at 1:38 PM
Edited Transcript of CGNT earnings conference call or presentation 7-Nov-17 9:30pm GMTEdited Transcript of CGNT earnings conference call or presentation 7-Nov-17 9:30pm GMT
finance.yahoo.com - November 8 at 8:51 PM
Why Cogentix Medical Inc (CGNT) Could Be A BuyWhy Cogentix Medical Inc (CGNT) Could Be A Buy
finance.yahoo.com - November 7 at 8:07 PM
Cogentix Medical Reports Third Quarter Results; Second Highest Quarterly Revenue in Company HistoryCogentix Medical Reports Third Quarter Results; Second Highest Quarterly Revenue in Company History
finance.yahoo.com - November 7 at 8:07 PM
Head to Head Analysis: BIOLASE (BLTI) & Cogentix Medical (CGNT)Head to Head Analysis: BIOLASE (BLTI) & Cogentix Medical (CGNT)
www.americanbankingnews.com - November 6 at 5:44 AM
ETFs with exposure to Cogentix Medical, Inc. : November 2, 2017ETFs with exposure to Cogentix Medical, Inc. : November 2, 2017
finance.yahoo.com - November 2 at 5:55 PM
Cogentix Medical, Inc. (CGNT) to Release Earnings on MondayCogentix Medical, Inc. (CGNT) to Release Earnings on Monday
www.americanbankingnews.com - October 30 at 3:28 AM
Cogentix Medical to Report Third Quarter Results on November 7, 2017Cogentix Medical to Report Third Quarter Results on November 7, 2017
finance.yahoo.com - October 25 at 6:40 PM
ETFs with exposure to Cogentix Medical, Inc. : October 20, 2017ETFs with exposure to Cogentix Medical, Inc. : October 20, 2017
finance.yahoo.com - October 20 at 3:29 PM
ETFs with exposure to Cogentix Medical, Inc. : October 9, 2017ETFs with exposure to Cogentix Medical, Inc. : October 9, 2017
finance.yahoo.com - October 9 at 5:47 PM
Cogentix Medical, Inc. :CGNT-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017Cogentix Medical, Inc. :CGNT-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017
finance.yahoo.com - October 6 at 5:23 PM
Cogentix Medical, Inc. (CGNT) Coverage Initiated by Analysts at JMP SecuritiesCogentix Medical, Inc. (CGNT) Coverage Initiated by Analysts at JMP Securities
www.americanbankingnews.com - October 6 at 9:12 AM
ABIOMED (ABMD) Banks on Impella Platform, Forex a Concern - NasdaqABIOMED (ABMD) Banks on Impella Platform, Forex a Concern - Nasdaq
www.nasdaq.com - September 28 at 10:09 PM
Cogentix Medical Makes $2 Million Investment in Israeli Company Developing Innovative and Novel Device for ... - PR Newswire (press release)Cogentix Medical Makes $2 Million Investment in Israeli Company Developing Innovative and Novel Device for ... - PR Newswire (press release)
www.prnewswire.com - September 28 at 10:09 PM
Cogentix Medical Makes $2 Million Investment in Israeli Company Developing Innovative and Novel Device for Delivery of Drugs to the BladderCogentix Medical Makes $2 Million Investment in Israeli Company Developing Innovative and Novel Device for Delivery of Drugs to the Bladder
finance.yahoo.com - September 28 at 5:07 PM
Allscripts Latest Initiative Eradicates Price AmbiguityAllscripts' Latest Initiative Eradicates Price Ambiguity
finance.yahoo.com - September 15 at 5:31 PM
DaVitas (DVA) Green Initiatives Win a Coveted Golden RewardDaVita's (DVA) Green Initiatives Win a Coveted Golden Reward
finance.yahoo.com - September 15 at 3:59 AM
Critical Analysis: Cogentix Medical (CGNT) and Thermo Fisher Scientific (TMO)Critical Analysis: Cogentix Medical (CGNT) and Thermo Fisher Scientific (TMO)
www.americanbankingnews.com - September 14 at 12:24 PM
Cogentix Medical Announces Cahaba GBA, LLC Extends Coverage for Urgent PC Maintenance TherapyCogentix Medical Announces Cahaba GBA, LLC Extends Coverage for Urgent PC Maintenance Therapy
finance.yahoo.com - September 13 at 6:22 PM
Head to Head Analysis: Cogentix Medical (CGNT) and The CompetitionHead to Head Analysis: Cogentix Medical (CGNT) and The Competition
www.americanbankingnews.com - September 11 at 12:08 AM
Civitas Solutions (CIVI) to Acquire Habilitative ServicesCivitas Solutions (CIVI) to Acquire Habilitative Services
www.zacks.com - August 24 at 5:14 PM
Will Cogentix Medical (CGNT) Continue to Surge Higher?Will Cogentix Medical (CGNT) Continue to Surge Higher?
www.nasdaq.com - August 9 at 5:20 PM
Edited Transcript of CGNT earnings conference call or presentation 1-Aug-17 8:30pm GMTEdited Transcript of CGNT earnings conference call or presentation 1-Aug-17 8:30pm GMT
finance.yahoo.com - August 2 at 5:53 PM
Cogentix Medical, Inc. (CGNT) Posts Quarterly  Earnings Results, Beats Expectations By $0.02 EPSCogentix Medical, Inc. (CGNT) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS
www.americanbankingnews.com - August 2 at 12:08 PM
Cogentix Medical Reports Strong Second Quarter Operating Results with 11% Urology Revenue Growth; Recently Executed Business Development Transactions Expected to Add Approximately 10 Points of Urology Revenue Growth in 2018Cogentix Medical Reports Strong Second Quarter Operating Results with 11% Urology Revenue Growth; Recently Executed Business Development Transactions Expected to Add Approximately 10 Points of Urology Revenue Growth in 2018
finance.yahoo.com - August 1 at 5:49 PM
Corporate News Blog - Cogentix Medical Acquires Genesis Medical to Further Increase Urology Products Revenue Growth RateCorporate News Blog - Cogentix Medical Acquires Genesis Medical to Further Increase Urology Products Revenue Growth Rate
finance.yahoo.com - July 28 at 6:47 PM
Perkins Capital Management Inc Buys AmerisourceBergen Corp, Pentair PLC, Zagg Inc, Sells ...Perkins Capital Management Inc Buys AmerisourceBergen Corp, Pentair PLC, Zagg Inc, Sells ...
www.nasdaq.com - July 27 at 4:35 PM
Cogentix Medical (CGNT) Acquires Genesis MedicalCogentix Medical (CGNT) Acquires Genesis Medical
www.streetinsider.com - July 27 at 3:40 AM
Cogentix Medical Acquires Genesis Medical; Transaction to Further Increase Urology Products Revenue Growth RateCogentix Medical Acquires Genesis Medical; Transaction to Further Increase Urology Products Revenue Growth Rate
finance.yahoo.com - July 26 at 5:44 PM
Cogentix Medical, Inc. (CGNT) Scheduled to Post Quarterly Earnings on TuesdayCogentix Medical, Inc. (CGNT) Scheduled to Post Quarterly Earnings on Tuesday
www.americanbankingnews.com - July 25 at 7:20 AM
Cogentix Medical to Report Second Quarter Results on August 1, 2017Cogentix Medical to Report Second Quarter Results on August 1, 2017
finance.yahoo.com - July 20 at 6:57 PM
Cogentix Medical Signs Agreement to Launch Endo-Urology Product Line in US; Launch to Further Increase Urology Products Growth Rate During 2018Cogentix Medical Signs Agreement to Launch Endo-Urology Product Line in US; Launch to Further Increase Urology Products Growth Rate During 2018
finance.yahoo.com - July 18 at 6:40 PM
ETFs with exposure to Cogentix Medical, Inc. : July 10, 2017ETFs with exposure to Cogentix Medical, Inc. : July 10, 2017
finance.yahoo.com - July 10 at 5:06 PM
Cogentix Medicals (CGNT) CEO Darin Hammers on Q1 2017 Results - Earnings Call TranscriptCogentix Medical's (CGNT) CEO Darin Hammers on Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - May 3 at 9:17 PM
COGENTIX MEDICAL INC /DE/ Files SEC form 10-K, Annual ReportCOGENTIX MEDICAL INC /DE/ Files SEC form 10-K, Annual Report
biz.yahoo.com - March 30 at 4:41 PM
COGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex
biz.yahoo.com - March 24 at 4:35 PM
Cogentix Medical (CGNT) Presents At 29th Annual ROTH Conference 2017Cogentix Medical (CGNT) Presents At 29th Annual ROTH Conference 2017
seekingalpha.com - March 14 at 4:08 PM
Q4 2016 Cogentix Medical Inc Earnings Release - Before Market OpenQ4 2016 Cogentix Medical Inc Earnings Release - Before Market Open
biz.yahoo.com - March 9 at 4:50 PM
COGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements andCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
biz.yahoo.com - March 9 at 4:50 PM
COGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Entry into a Material Definitive AgreementCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement
biz.yahoo.com - January 6 at 4:38 PM
COGENTIX MEDICAL INC /DE/ Files SEC form 8-K/A, Change in Directors or Principal OfficersCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K/A, Change in Directors or Principal Officers
biz.yahoo.com - January 3 at 10:59 PM
Q3 2016 Cogentix Medical Inc Earnings Release - After Market CloseQ3 2016 Cogentix Medical Inc Earnings Release - After Market Close
biz.yahoo.com - November 8 at 2:18 PM
COGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material DCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material D
biz.yahoo.com - November 4 at 9:28 PM
COGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
biz.yahoo.com - September 26 at 4:25 PM
COGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, OtherCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other
biz.yahoo.com - September 13 at 9:00 AM
[$$] Accelmed Making $25 Million Equity Investment in Cogentix[$$] Accelmed Making $25 Million Equity Investment in Cogentix
www.wsj.com - September 7 at 9:15 PM
COGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of EquityCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity
biz.yahoo.com - September 7 at 8:56 AM
COGENTIX MEDICAL INC /DE/ Files SEC form 10-Q, Quarterly ReportCOGENTIX MEDICAL INC /DE/ Files SEC form 10-Q, Quarterly Report
biz.yahoo.com - August 15 at 11:26 AM
Cogentix names CEO after management shake-upCogentix names CEO after management shake-up
www.bizjournals.com - July 12 at 9:39 PM

Social Media

Financials

Chart

Cogentix Medical (NASDAQ CGNT) Chart for Monday, November, 20, 2017
Loading chart…

This page was last updated on 11/20/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.